Metformin Use in Patients With Historical Contraindications

Affiliations

Comment

Kasia J Lipska. Ann Intern Med. 2017.

. 2017 Feb 7;166(3):225-226.

doi: 10.7326/M16-2712. Epub 2017 Jan 3.

No abstract available

Comment on

Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review.
Crowley MJ, Diamantidis CJ, McDuffie JR, Cameron CB, Stanifer JW, Mock CK, Wang X, Tang S, Nagi A, Kosinski AS, Williams JW Jr. Crowley MJ, et al. Ann Intern Med. 2017 Feb 7;166(3):191-200. doi: 10.7326/M16-1901. Epub 2017 Jan 3. Ann Intern Med. 2017. PMID: 28055049 Free PMC article.

1. Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care. 2006;29:725–31. - PubMed
1. Misbin RI, Green L, Stadel BV, Gueriguian JL, Gubbi A, Fleming GA. Lactic acidosis in patients with diabetes treated with metformin [Letter] N Engl J Med. 1998;338:265–6. - PubMed
1. Inzucchi SE, Masoudi FA, McGuire DK. Metformin in heart failure [Letter] Diabetes Care. 2007;30:e129. - PubMed
1. Lipska KJ, Flory JH, Hennessy S, Inzucchi SE. Citizen petition to the US Food and Drug Administration to change prescribing guidelines: the metformin experience. Circulation. 2016;134:1405–1408. - PMC - PubMed
1. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–89. doi: 10.1056/NEJMoa0806470. - DOI - PubMed